HomeMLYS • NASDAQ
add
Mineralys Therapeutics Inc
Previous close
$13.75
Day range
$13.61 - $14.31
Year range
$5.85 - $17.70
Market cap
703.27M USD
Avg Volume
124.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 27.71M | 176.89% |
Net income | -24.39M | -168.81% |
Net profit margin | — | — |
Earnings per share | -0.61 | 64.94% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 236.57M | 114.85% |
Total assets | 251.64M | 119.88% |
Total liabilities | 10.48M | 29.94% |
Total equity | 241.15M | — |
Shares outstanding | 49.63M | — |
Price to book | 2.35 | — |
Return on assets | -26.18% | — |
Return on capital | -27.43% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -24.39M | -168.81% |
Cash from operations | -28.98M | -184.52% |
Cash from investing | -8.09M | -116.18% |
Cash from financing | 74.00K | 106.93% |
Net change in cash | -37.00M | -195.48% |
Free cash flow | -19.85M | -185.22% |
About
Founded
2019
Website
Employees
28